nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Sorafenib—liver cancer	0.131	0.216	CbGbCtD
Efavirenz—CYP2C19—Sorafenib—liver cancer	0.0831	0.137	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—liver cancer	0.0794	0.131	CbGbCtD
Efavirenz—CYP1A2—Sorafenib—liver cancer	0.0767	0.127	CbGbCtD
Efavirenz—CYP2C9—Sorafenib—liver cancer	0.0691	0.114	CbGbCtD
Efavirenz—CYP2D6—Sorafenib—liver cancer	0.0632	0.104	CbGbCtD
Efavirenz—CYP3A4—Sorafenib—liver cancer	0.0402	0.0664	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—liver cancer	0.0384	0.0634	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—liver cancer	0.0244	0.0403	CbGbCtD
Efavirenz—Hepatic failure—Epirubicin—liver cancer	0.000621	0.00232	CcSEcCtD
Efavirenz—Abnormal vision—Doxorubicin—liver cancer	0.00062	0.00232	CcSEcCtD
Efavirenz—Mental disability—Doxorubicin—liver cancer	0.000617	0.00231	CcSEcCtD
Efavirenz—Cardiac failure congestive—Epirubicin—liver cancer	0.000615	0.0023	CcSEcCtD
Efavirenz—Gastrointestinal pain—Sorafenib—liver cancer	0.000607	0.00227	CcSEcCtD
Efavirenz—Renal failure acute—Epirubicin—liver cancer	0.000604	0.00226	CcSEcCtD
Efavirenz—Hot flush—Epirubicin—liver cancer	0.000596	0.00223	CcSEcCtD
Efavirenz—Thrombophlebitis—Doxorubicin—liver cancer	0.000596	0.00223	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Epirubicin—liver cancer	0.000591	0.00221	CcSEcCtD
Efavirenz—Menopausal symptoms—Epirubicin—liver cancer	0.000591	0.00221	CcSEcCtD
Efavirenz—Urticaria—Sorafenib—liver cancer	0.00059	0.0022	CcSEcCtD
Efavirenz—Abdominal pain—Sorafenib—liver cancer	0.000587	0.00219	CcSEcCtD
Efavirenz—Body temperature increased—Sorafenib—liver cancer	0.000587	0.00219	CcSEcCtD
Efavirenz—Renal impairment—Epirubicin—liver cancer	0.000586	0.00219	CcSEcCtD
Efavirenz—Dermatitis bullous—Epirubicin—liver cancer	0.000584	0.00218	CcSEcCtD
Efavirenz—Eczema—Doxorubicin—liver cancer	0.000574	0.00215	CcSEcCtD
Efavirenz—Hepatic failure—Doxorubicin—liver cancer	0.000574	0.00215	CcSEcCtD
Efavirenz—Cardiac failure congestive—Doxorubicin—liver cancer	0.000569	0.00213	CcSEcCtD
Efavirenz—Renal failure acute—Doxorubicin—liver cancer	0.000559	0.00209	CcSEcCtD
Efavirenz—Diplopia—Epirubicin—liver cancer	0.000558	0.00208	CcSEcCtD
Efavirenz—Hot flush—Doxorubicin—liver cancer	0.000552	0.00206	CcSEcCtD
Efavirenz—Migraine—Epirubicin—liver cancer	0.000549	0.00205	CcSEcCtD
Efavirenz—Affect lability—Epirubicin—liver cancer	0.000549	0.00205	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000547	0.00204	CcSEcCtD
Efavirenz—Menopausal symptoms—Doxorubicin—liver cancer	0.000547	0.00204	CcSEcCtD
Efavirenz—Hypersensitivity—Sorafenib—liver cancer	0.000547	0.00204	CcSEcCtD
Efavirenz—Renal impairment—Doxorubicin—liver cancer	0.000542	0.00203	CcSEcCtD
Efavirenz—Dermatitis bullous—Doxorubicin—liver cancer	0.00054	0.00202	CcSEcCtD
Efavirenz—Asthenia—Sorafenib—liver cancer	0.000532	0.00199	CcSEcCtD
Efavirenz—Mood swings—Epirubicin—liver cancer	0.000529	0.00197	CcSEcCtD
Efavirenz—Pruritus—Sorafenib—liver cancer	0.000525	0.00196	CcSEcCtD
Efavirenz—Ataxia—Epirubicin—liver cancer	0.000525	0.00196	CcSEcCtD
Efavirenz—Blood creatinine increased—Epirubicin—liver cancer	0.000523	0.00195	CcSEcCtD
Efavirenz—Diplopia—Doxorubicin—liver cancer	0.000516	0.00193	CcSEcCtD
Efavirenz—Affect lability—Doxorubicin—liver cancer	0.000508	0.0019	CcSEcCtD
Efavirenz—Migraine—Doxorubicin—liver cancer	0.000508	0.0019	CcSEcCtD
Efavirenz—Hypokalaemia—Epirubicin—liver cancer	0.000508	0.0019	CcSEcCtD
Efavirenz—Diarrhoea—Sorafenib—liver cancer	0.000508	0.0019	CcSEcCtD
Efavirenz—Breast disorder—Epirubicin—liver cancer	0.000504	0.00188	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000502	0.00188	CcSEcCtD
Efavirenz—Nasopharyngitis—Epirubicin—liver cancer	0.000499	0.00186	CcSEcCtD
Efavirenz—Muscular weakness—Epirubicin—liver cancer	0.000492	0.00184	CcSEcCtD
Efavirenz—Dizziness—Sorafenib—liver cancer	0.000491	0.00183	CcSEcCtD
Efavirenz—Mood swings—Doxorubicin—liver cancer	0.000489	0.00183	CcSEcCtD
Efavirenz—Abdominal distension—Epirubicin—liver cancer	0.000485	0.00181	CcSEcCtD
Efavirenz—Ataxia—Doxorubicin—liver cancer	0.000485	0.00181	CcSEcCtD
Efavirenz—Blood creatinine increased—Doxorubicin—liver cancer	0.000484	0.00181	CcSEcCtD
Efavirenz—Asthma—Epirubicin—liver cancer	0.000482	0.0018	CcSEcCtD
Efavirenz—Pancreatitis—Epirubicin—liver cancer	0.000473	0.00177	CcSEcCtD
Efavirenz—Vomiting—Sorafenib—liver cancer	0.000472	0.00176	CcSEcCtD
Efavirenz—Hypokalaemia—Doxorubicin—liver cancer	0.00047	0.00175	CcSEcCtD
Efavirenz—Rash—Sorafenib—liver cancer	0.000468	0.00175	CcSEcCtD
Efavirenz—Dermatitis—Sorafenib—liver cancer	0.000467	0.00175	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—liver cancer	0.000467	0.00174	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000465	0.00174	CcSEcCtD
Efavirenz—Headache—Sorafenib—liver cancer	0.000465	0.00174	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—liver cancer	0.000462	0.00172	CcSEcCtD
Efavirenz—Pancytopenia—Epirubicin—liver cancer	0.000458	0.00171	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—liver cancer	0.000455	0.0017	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—liver cancer	0.000449	0.00168	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Epirubicin—liver cancer	0.000448	0.00167	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—liver cancer	0.000446	0.00167	CcSEcCtD
Efavirenz—Nausea—Sorafenib—liver cancer	0.000441	0.00165	CcSEcCtD
Efavirenz—Photosensitivity reaction—Epirubicin—liver cancer	0.00044	0.00164	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—liver cancer	0.000437	0.00163	CcSEcCtD
Efavirenz—Hyperglycaemia—Epirubicin—liver cancer	0.000435	0.00162	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—liver cancer	0.000432	0.00162	CcSEcCtD
Efavirenz—Infestation—Epirubicin—liver cancer	0.00043	0.00161	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—liver cancer	0.00043	0.00161	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—liver cancer	0.00043	0.00161	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000426	0.00159	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—liver cancer	0.000424	0.00158	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—liver cancer	0.000423	0.00158	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—liver cancer	0.000421	0.00157	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—liver cancer	0.000419	0.00157	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000415	0.00155	CcSEcCtD
Efavirenz—Sweating—Epirubicin—liver cancer	0.000412	0.00154	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—liver cancer	0.00041	0.00153	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—liver cancer	0.000407	0.00152	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—liver cancer	0.000407	0.00152	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—liver cancer	0.000403	0.00151	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—liver cancer	0.000403	0.0015	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—liver cancer	0.0004	0.00149	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—liver cancer	0.000398	0.00149	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—liver cancer	0.000398	0.00149	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—liver cancer	0.000398	0.00149	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000394	0.00147	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—liver cancer	0.000391	0.00146	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—liver cancer	0.00039	0.00146	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—liver cancer	0.000388	0.00145	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—liver cancer	0.000387	0.00145	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—liver cancer	0.000386	0.00144	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—liver cancer	0.000384	0.00143	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—liver cancer	0.000381	0.00142	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—liver cancer	0.000381	0.00142	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—liver cancer	0.00038	0.00142	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—liver cancer	0.000379	0.00142	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—liver cancer	0.000379	0.00142	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—liver cancer	0.000378	0.00141	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—liver cancer	0.000376	0.00141	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—liver cancer	0.000373	0.00139	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—liver cancer	0.000372	0.00139	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—liver cancer	0.000365	0.00136	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—liver cancer	0.000361	0.00135	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—liver cancer	0.00036	0.00134	CcSEcCtD
Efavirenz—Flushing—Epirubicin—liver cancer	0.000358	0.00134	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—liver cancer	0.000358	0.00134	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—liver cancer	0.000358	0.00134	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—liver cancer	0.000357	0.00133	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—liver cancer	0.000355	0.00133	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—liver cancer	0.000353	0.00132	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—liver cancer	0.000352	0.00131	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—liver cancer	0.000351	0.00131	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—liver cancer	0.00035	0.00131	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—liver cancer	0.00035	0.00131	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—liver cancer	0.000349	0.0013	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—liver cancer	0.000348	0.0013	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—liver cancer	0.000345	0.00129	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—liver cancer	0.000344	0.00129	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—liver cancer	0.000341	0.00127	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—liver cancer	0.000338	0.00126	CcSEcCtD
Efavirenz—Erythema—Epirubicin—liver cancer	0.000336	0.00126	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—liver cancer	0.000336	0.00126	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—liver cancer	0.000334	0.00125	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—liver cancer	0.000333	0.00124	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—liver cancer	0.000331	0.00124	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—liver cancer	0.000331	0.00124	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—liver cancer	0.000331	0.00124	CcSEcCtD
Efavirenz—Tension—Epirubicin—liver cancer	0.00033	0.00123	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—liver cancer	0.000329	0.00123	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—liver cancer	0.000326	0.00122	CcSEcCtD
Efavirenz—Back pain—Epirubicin—liver cancer	0.000325	0.00121	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—liver cancer	0.000324	0.00121	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—liver cancer	0.000323	0.0012	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—liver cancer	0.000322	0.0012	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—liver cancer	0.000319	0.00119	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—liver cancer	0.000317	0.00118	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—liver cancer	0.000316	0.00118	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—liver cancer	0.000312	0.00116	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—liver cancer	0.000311	0.00116	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—liver cancer	0.000311	0.00116	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—liver cancer	0.000311	0.00116	CcSEcCtD
Efavirenz—Agitation—Epirubicin—liver cancer	0.000309	0.00115	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—liver cancer	0.000306	0.00114	CcSEcCtD
Efavirenz—Tension—Doxorubicin—liver cancer	0.000305	0.00114	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—liver cancer	0.000304	0.00114	CcSEcCtD
Efavirenz—Malaise—Epirubicin—liver cancer	0.000303	0.00113	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—liver cancer	0.000302	0.00113	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—liver cancer	0.000302	0.00113	CcSEcCtD
Efavirenz—Syncope—Epirubicin—liver cancer	0.000301	0.00113	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—liver cancer	0.000301	0.00112	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—liver cancer	0.000297	0.00111	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—liver cancer	0.000295	0.0011	CcSEcCtD
Efavirenz—Cough—Epirubicin—liver cancer	0.000293	0.0011	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—liver cancer	0.000293	0.00109	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—liver cancer	0.000291	0.00109	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—liver cancer	0.00029	0.00108	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—liver cancer	0.000288	0.00108	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—liver cancer	0.000287	0.00107	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—liver cancer	0.000286	0.00107	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—liver cancer	0.000286	0.00107	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—liver cancer	0.000286	0.00107	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—liver cancer	0.000286	0.00107	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—liver cancer	0.000285	0.00106	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000284	0.00106	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—liver cancer	0.000283	0.00106	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—liver cancer	0.00028	0.00105	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—liver cancer	0.00028	0.00104	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—liver cancer	0.000279	0.00104	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—liver cancer	0.000279	0.00104	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—liver cancer	0.000277	0.00103	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—liver cancer	0.000275	0.00103	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—liver cancer	0.000273	0.00102	CcSEcCtD
Efavirenz—Cough—Doxorubicin—liver cancer	0.000271	0.00101	CcSEcCtD
Efavirenz—Shock—Epirubicin—liver cancer	0.00027	0.00101	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—liver cancer	0.000269	0.00101	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—liver cancer	0.000269	0.001	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—liver cancer	0.000269	0.001	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—liver cancer	0.000268	0.001	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—liver cancer	0.000268	0.001	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—liver cancer	0.000266	0.000995	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—liver cancer	0.000265	0.00099	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—liver cancer	0.000265	0.000989	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—liver cancer	0.000265	0.000989	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—liver cancer	0.000265	0.000989	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—liver cancer	0.000264	0.000985	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000263	0.000982	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—liver cancer	0.000262	0.000977	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—liver cancer	0.000261	0.000976	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—liver cancer	0.000259	0.000967	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—liver cancer	0.000256	0.000956	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00025	0.000933	CcSEcCtD
Efavirenz—Shock—Doxorubicin—liver cancer	0.00025	0.000932	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—liver cancer	0.000249	0.000929	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—liver cancer	0.000248	0.000928	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—liver cancer	0.000248	0.000926	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—liver cancer	0.000248	0.000925	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—liver cancer	0.000246	0.000921	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—liver cancer	0.000246	0.00092	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—liver cancer	0.000245	0.000916	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—liver cancer	0.000244	0.000913	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—liver cancer	0.000244	0.000911	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—liver cancer	0.000242	0.000903	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—liver cancer	0.000241	0.000902	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—liver cancer	0.000238	0.00089	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—liver cancer	0.000237	0.000884	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—liver cancer	0.000236	0.000883	CcSEcCtD
Efavirenz—Constipation—Epirubicin—liver cancer	0.000235	0.000876	CcSEcCtD
Efavirenz—Pain—Epirubicin—liver cancer	0.000235	0.000876	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000231	0.000863	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—liver cancer	0.00023	0.000857	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—liver cancer	0.000228	0.000851	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—liver cancer	0.000226	0.000845	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—liver cancer	0.000226	0.000844	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—liver cancer	0.000226	0.000843	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—liver cancer	0.000224	0.000838	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—liver cancer	0.000223	0.000834	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—liver cancer	0.000221	0.000824	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000219	0.000818	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—liver cancer	0.000219	0.000817	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—liver cancer	0.000218	0.000814	CcSEcCtD
Efavirenz—Pain—Doxorubicin—liver cancer	0.000217	0.00081	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—liver cancer	0.000217	0.00081	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—liver cancer	0.000217	0.00081	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—liver cancer	0.000217	0.00081	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—liver cancer	0.000209	0.000781	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—liver cancer	0.000207	0.000775	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—liver cancer	0.000202	0.000755	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—liver cancer	0.000202	0.000753	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—liver cancer	0.000201	0.000749	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—liver cancer	0.000201	0.000749	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—liver cancer	0.000197	0.000735	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—liver cancer	0.000194	0.000725	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—liver cancer	0.000188	0.000701	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—liver cancer	0.000187	0.000698	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—liver cancer	0.000182	0.00068	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—liver cancer	0.000181	0.000677	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—liver cancer	0.00018	0.000671	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—liver cancer	0.000174	0.000651	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—liver cancer	0.000174	0.000648	CcSEcCtD
Efavirenz—Rash—Epirubicin—liver cancer	0.000173	0.000646	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—liver cancer	0.000173	0.000645	CcSEcCtD
Efavirenz—Headache—Epirubicin—liver cancer	0.000172	0.000642	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—liver cancer	0.000168	0.000627	CcSEcCtD
Efavirenz—Nausea—Epirubicin—liver cancer	0.000163	0.000608	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—liver cancer	0.000161	0.000603	CcSEcCtD
Efavirenz—Rash—Doxorubicin—liver cancer	0.00016	0.000598	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—liver cancer	0.00016	0.000597	CcSEcCtD
Efavirenz—Headache—Doxorubicin—liver cancer	0.000159	0.000594	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—liver cancer	0.000151	0.000563	CcSEcCtD
Efavirenz—CYP3A4—Biological oxidations—CYP2E1—liver cancer	8.34e-05	0.000657	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	8.23e-05	0.000648	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTM1—liver cancer	8.19e-05	0.000646	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	8.08e-05	0.000637	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.9e-05	0.000623	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP1A1—liver cancer	7.76e-05	0.000612	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GGT1—liver cancer	7.66e-05	0.000604	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	7.66e-05	0.000604	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.62e-05	0.0006	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	7.55e-05	0.000595	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.48e-05	0.000589	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—UGDH—liver cancer	7.45e-05	0.000587	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—EPT1—liver cancer	7.01e-05	0.000552	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTP1—liver cancer	6.88e-05	0.000542	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—UGDH—liver cancer	6.86e-05	0.00054	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.82e-05	0.000537	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—UGDH—liver cancer	6.8e-05	0.000536	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.78e-05	0.000535	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TAT—liver cancer	6.64e-05	0.000524	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.53e-05	0.000515	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EPT1—liver cancer	6.45e-05	0.000508	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EPT1—liver cancer	6.39e-05	0.000504	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.32e-05	0.000498	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.23e-05	0.000491	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TAT—liver cancer	6.11e-05	0.000482	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TAT—liver cancer	6.06e-05	0.000477	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.99e-05	0.000472	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CPT1B—liver cancer	5.98e-05	0.000471	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GLUL—liver cancer	5.98e-05	0.000471	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.96e-05	0.00047	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.91e-05	0.000466	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.82e-05	0.000459	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UGDH—liver cancer	5.81e-05	0.000458	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NR1H4—liver cancer	5.76e-05	0.000454	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTA3—liver cancer	5.66e-05	0.000446	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—EPT1—liver cancer	5.46e-05	0.00043	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTA4—liver cancer	5.18e-05	0.000408	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TAT—liver cancer	5.18e-05	0.000408	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.09e-05	0.000401	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTA2—liver cancer	5.05e-05	0.000398	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.89e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTA1—liver cancer	4.87e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NAT2—liver cancer	4.82e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALDOB—liver cancer	4.62e-05	0.000364	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CPT1B—liver cancer	4.52e-05	0.000356	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GLUL—liver cancer	4.52e-05	0.000356	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UGDH—liver cancer	4.48e-05	0.000353	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.46e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CRABP1—liver cancer	4.41e-05	0.000347	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NR1H4—liver cancer	4.35e-05	0.000343	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTA3—liver cancer	4.28e-05	0.000337	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EPT1—liver cancer	4.21e-05	0.000332	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GLUL—liver cancer	4.15e-05	0.000327	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CPT1B—liver cancer	4.15e-05	0.000327	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GLUL—liver cancer	4.12e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CPT1B—liver cancer	4.12e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NR1H4—liver cancer	4e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TAT—liver cancer	3.99e-05	0.000315	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NR1H4—liver cancer	3.97e-05	0.000313	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTA3—liver cancer	3.94e-05	0.00031	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTA4—liver cancer	3.92e-05	0.000309	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTA3—liver cancer	3.9e-05	0.000308	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HPGDS—liver cancer	3.85e-05	0.000303	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.83e-05	0.000302	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTA2—liver cancer	3.82e-05	0.000301	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.81e-05	0.0003	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTA1—liver cancer	3.68e-05	0.00029	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NAT2—liver cancer	3.64e-05	0.000287	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTA4—liver cancer	3.6e-05	0.000284	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTA4—liver cancer	3.57e-05	0.000281	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GLUL—liver cancer	3.52e-05	0.000277	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CPT1B—liver cancer	3.52e-05	0.000277	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTA2—liver cancer	3.51e-05	0.000277	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.5e-05	0.000276	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDOB—liver cancer	3.49e-05	0.000275	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.49e-05	0.000275	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTA2—liver cancer	3.48e-05	0.000274	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PSMA4—liver cancer	3.43e-05	0.000271	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PSMD10—liver cancer	3.43e-05	0.000271	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NR1H4—liver cancer	3.39e-05	0.000267	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTA1—liver cancer	3.39e-05	0.000267	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTA1—liver cancer	3.36e-05	0.000265	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NAT2—liver cancer	3.35e-05	0.000264	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GOT2—liver cancer	3.34e-05	0.000263	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA3—liver cancer	3.34e-05	0.000263	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CRABP1—liver cancer	3.33e-05	0.000262	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NAT2—liver cancer	3.32e-05	0.000262	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDOB—liver cancer	3.21e-05	0.000253	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.19e-05	0.000252	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDOB—liver cancer	3.18e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2E1—liver cancer	3.14e-05	0.000247	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CRABP1—liver cancer	3.06e-05	0.000241	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA4—liver cancer	3.05e-05	0.00024	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CRABP1—liver cancer	3.04e-05	0.000239	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3e-05	0.000236	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.98e-05	0.000235	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA2—liver cancer	2.97e-05	0.000234	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYCS—liver cancer	2.94e-05	0.000231	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HPGDS—liver cancer	2.91e-05	0.000229	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.89e-05	0.000228	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GGT1—liver cancer	2.88e-05	0.000227	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GOT1—liver cancer	2.88e-05	0.000227	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA1—liver cancer	2.87e-05	0.000226	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NAT2—liver cancer	2.84e-05	0.000224	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.73e-05	0.000215	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.73e-05	0.000215	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDOB—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CPT1B—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GLUL—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HPGDS—liver cancer	2.68e-05	0.000211	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HPGDS—liver cancer	2.65e-05	0.000209	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.64e-05	0.000208	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.63e-05	0.000208	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NR1H4—liver cancer	2.62e-05	0.000206	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.6e-05	0.000205	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CRABP1—liver cancer	2.59e-05	0.000204	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMD10—liver cancer	2.59e-05	0.000204	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMA4—liver cancer	2.59e-05	0.000204	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—liver cancer	2.59e-05	0.000204	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA3—liver cancer	2.57e-05	0.000203	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—liver cancer	2.55e-05	0.000201	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT2—liver cancer	2.52e-05	0.000199	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.4e-05	0.000189	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMD10—liver cancer	2.39e-05	0.000188	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMA4—liver cancer	2.39e-05	0.000188	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—liver cancer	2.38e-05	0.000187	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—liver cancer	2.37e-05	0.000187	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.37e-05	0.000187	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMA4—liver cancer	2.36e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMD10—liver cancer	2.36e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA4—liver cancer	2.35e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.34e-05	0.000184	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GOT2—liver cancer	2.32e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT2—liver cancer	2.3e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.3e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA2—liver cancer	2.29e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HPGDS—liver cancer	2.27e-05	0.000179	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—liver cancer	2.26e-05	0.000178	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.25e-05	0.000178	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYCS—liver cancer	2.22e-05	0.000175	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA1—liver cancer	2.21e-05	0.000174	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAT2—liver cancer	2.19e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—liver cancer	2.18e-05	0.000172	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GGT1—liver cancer	2.18e-05	0.000172	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT1—liver cancer	2.18e-05	0.000172	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—liver cancer	2.16e-05	0.00017	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—liver cancer	2.1e-05	0.000166	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOB—liver cancer	2.1e-05	0.000165	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.09e-05	0.000165	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARA—liver cancer	2.06e-05	0.000163	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.05e-05	0.000162	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYCS—liver cancer	2.04e-05	0.000161	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.03e-05	0.00016	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYCS—liver cancer	2.02e-05	0.000159	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMA4—liver cancer	2.02e-05	0.000159	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMD10—liver cancer	2.02e-05	0.000159	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GGT1—liver cancer	2e-05	0.000158	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GOT1—liver cancer	2e-05	0.000158	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CRABP1—liver cancer	2e-05	0.000158	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT1—liver cancer	1.99e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GGT1—liver cancer	1.99e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GOT2—liver cancer	1.97e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—liver cancer	1.96e-05	0.000154	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—liver cancer	1.93e-05	0.000152	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—liver cancer	1.85e-05	0.000146	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—liver cancer	1.8e-05	0.000142	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—liver cancer	1.8e-05	0.000142	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.79e-05	0.000141	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—liver cancer	1.78e-05	0.000141	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—liver cancer	1.77e-05	0.00014	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—liver cancer	1.77e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—liver cancer	1.76e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HPGDS—liver cancer	1.75e-05	0.000138	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYCS—liver cancer	1.73e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—liver cancer	1.7e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—liver cancer	1.7e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GGT1—liver cancer	1.7e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GOT1—liver cancer	1.7e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—liver cancer	1.65e-05	0.00013	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—liver cancer	1.64e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—liver cancer	1.59e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—liver cancer	1.57e-05	0.000124	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMD10—liver cancer	1.56e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMA4—liver cancer	1.56e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARA—liver cancer	1.56e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—liver cancer	1.55e-05	0.000122	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—liver cancer	1.55e-05	0.000122	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—liver cancer	1.53e-05	0.000121	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—liver cancer	1.52e-05	0.00012	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GOT2—liver cancer	1.52e-05	0.00012	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—liver cancer	1.5e-05	0.000118	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—liver cancer	1.46e-05	0.000115	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—liver cancer	1.45e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARA—liver cancer	1.43e-05	0.000113	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—liver cancer	1.43e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARA—liver cancer	1.42e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—liver cancer	1.4e-05	0.00011	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.4e-05	0.00011	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—liver cancer	1.35e-05	0.000107	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—liver cancer	1.33e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYCS—liver cancer	1.33e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—liver cancer	1.33e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GGT1—liver cancer	1.31e-05	0.000103	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GOT1—liver cancer	1.31e-05	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—liver cancer	1.29e-05	0.000102	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.28e-05	0.000101	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—liver cancer	1.24e-05	9.76e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—liver cancer	1.23e-05	9.68e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—liver cancer	1.22e-05	9.59e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARA—liver cancer	1.21e-05	9.57e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—liver cancer	1.18e-05	9.34e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—liver cancer	1.18e-05	9.27e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—liver cancer	1.17e-05	9.26e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—liver cancer	1.17e-05	9.25e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—liver cancer	1.16e-05	9.14e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—liver cancer	1.16e-05	9.13e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.09e-05	8.6e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—liver cancer	1.08e-05	8.52e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—liver cancer	1.08e-05	8.51e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—liver cancer	1.07e-05	8.43e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—liver cancer	1.07e-05	8.4e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—liver cancer	1.06e-05	8.33e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—liver cancer	1.04e-05	8.2e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—liver cancer	1.02e-05	8.08e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—liver cancer	1.02e-05	8.06e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—liver cancer	1e-05	7.91e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—liver cancer	9.55e-06	7.53e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—liver cancer	9.41e-06	7.41e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARA—liver cancer	9.37e-06	7.39e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—liver cancer	9.33e-06	7.35e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—liver cancer	9.14e-06	7.21e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—liver cancer	9.03e-06	7.11e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—liver cancer	8.25e-06	6.5e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—liver cancer	8.03e-06	6.33e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—liver cancer	7.97e-06	6.28e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—liver cancer	7.75e-06	6.11e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—liver cancer	7.06e-06	5.56e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—liver cancer	6.97e-06	5.49e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—liver cancer	6.74e-06	5.31e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—liver cancer	6.24e-06	4.91e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—liver cancer	6.15e-06	4.85e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—liver cancer	5.74e-06	4.52e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—liver cancer	5.69e-06	4.48e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—liver cancer	5.09e-06	4.01e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—liver cancer	4.86e-06	3.83e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—liver cancer	4.69e-06	3.69e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—liver cancer	4.64e-06	3.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—liver cancer	3.97e-06	3.13e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—liver cancer	3.75e-06	2.96e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—liver cancer	3.06e-06	2.41e-05	CbGpPWpGaD
